Intraoperative Hypotension and Post-anesthesia Care Unit Recovery

January 18, 2023 updated by: Acibadem University

Different Types of Intraoperative Hypotension and Their Association With Post-anesthesia Care Unit Recovery

The underlying causative mechanism that leads to intraoperative hypotension (IOH) may vary depending on the stage of anesthesia and surgery, which determines different IOH types. Naturally, the incidence and severity of IOH types will differ, as will the incidence and severity of postoperative complications.

Study Overview

Detailed Description

Background The underlying causative mechanism that leads to intraoperative hypotension (IOH) may vary depending on the stage of anesthesia and surgery, which determines different IOH types. Naturally, the incidence and severity of IOH types will differ, as will the incidence and severity of postoperative complications.

Methods The investigators conducted a data-based observational study that included 4776 patients. Post-induction hypotension (pIOH) is defined as a decrease during the first 20 min after anesthesia induction and maintenance intraoperative hypotension (mIOH) when there is a decrease of blood pressure 20th min after induction, with or without pIOH.

Study Type

Observational

Enrollment (Actual)

4776

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34662
        • Acibadem University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

We conducted a data-based observational study. Only routinely documented patient data was considered in the recent study. All patients' preoperative and postoperative recovery room data is recorded in a virtual environment. Data describing consecutive patients were collected until the patient was discharged to a ward. Data included demographics, comorbidities, perioperative hemodynamic parameters, duration of PACU, complications in PACU, and non-planned intensive care admission.

Description

Inclusion Criteria:

  • 18 years and older
  • Underwent elective surgery
  • Received general anesthesia
  • Planned overnight stay in the hospital after surgery

Exclusion Criteria:

  • Under 18 years of age
  • Cardiac surgery
  • Transplant surgery
  • Preoperatively receiving vasoactive drugs
  • Patients with mechanical circulatory support
  • Pediatric surgery
  • Patients from ICU
  • Patients with scheduled postoperative ICU admissions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Post-induction hypotension
Post-induction hypotension (pIOH) is a decrease during the first 20 min after anesthesia induction

For the purposes of this study, we defined intraoperative hypotension as a decrease in mean blood pressure of 30% from baseline for a minimum of 5 minutes, including induction and maintenance of anesthesia. The measuring blood pressure method (noninvasive or invasive) depended on the surgical intervention's invasiveness and the patient's cardiac performance.

As soon as the patients entered the PACU, the responsible nurses started the standard monitoring. Anesthesiologists constantly oversee all actions based on the patient's condition. Clinical observation for respiratory and gastrointestinal problems and all disorders were monitored. When in room air SO2 was <94, we started oxygen treatment with a 4 liter/minute nasal cannula, and in cases of nausea antiemetic was administered. The Modified Aldrete Score was used to discharge the patent.

Other Names:
  • Postoperative clinical observation
Maintenance intraoperative hypotension
maintenance intraoperative hypotension (mIOH) when there is a decrease of blood pressure 20th min after induction, with or without pIOH

For the purposes of this study, we defined intraoperative hypotension as a decrease in mean blood pressure of 30% from baseline for a minimum of 5 minutes, including induction and maintenance of anesthesia. The measuring blood pressure method (noninvasive or invasive) depended on the surgical intervention's invasiveness and the patient's cardiac performance.

As soon as the patients entered the PACU, the responsible nurses started the standard monitoring. Anesthesiologists constantly oversee all actions based on the patient's condition. Clinical observation for respiratory and gastrointestinal problems and all disorders were monitored. When in room air SO2 was <94, we started oxygen treatment with a 4 liter/minute nasal cannula, and in cases of nausea antiemetic was administered. The Modified Aldrete Score was used to discharge the patent.

Other Names:
  • Postoperative clinical observation
Normotensive patients
Patients with normotension during surgery.

For the purposes of this study, we defined intraoperative hypotension as a decrease in mean blood pressure of 30% from baseline for a minimum of 5 minutes, including induction and maintenance of anesthesia. The measuring blood pressure method (noninvasive or invasive) depended on the surgical intervention's invasiveness and the patient's cardiac performance.

As soon as the patients entered the PACU, the responsible nurses started the standard monitoring. Anesthesiologists constantly oversee all actions based on the patient's condition. Clinical observation for respiratory and gastrointestinal problems and all disorders were monitored. When in room air SO2 was <94, we started oxygen treatment with a 4 liter/minute nasal cannula, and in cases of nausea antiemetic was administered. The Modified Aldrete Score was used to discharge the patent.

Other Names:
  • Postoperative clinical observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of IOH types on PACU recovery (Duration)
Time Frame: From the preoperative first monitorization of the patient in the operating room until until discharege from the PACU (0-720 minutes).

The underlying causative mechanism that leads to IOH may vary depending on the stage of anesthesia and surgery, which determines different IOH types; therefore recovery after them will differ.

care unit (PACU) recovery, especially duration and complications in the PACU.

From the preoperative first monitorization of the patient in the operating room until until discharege from the PACU (0-720 minutes).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PACU recovery
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Compare the effect of intraoperative hypotension types on PACU recovery to the effect of other factors influencing PACU recovery.
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of IOH types on PACU duration
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Different IOH types may have a different impact on the PACU duration.
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Effect of IOH types on PACU complications
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Different IOH types have a different impact on the PACU's complication rate.
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Intraoperative hypotension
Time Frame: From the preoperative first monitorization of the patient in the operating room until extubation and transfer to the PACU (0-480 minutes).
Decrease in mean blood pressure of 30% from baseline for a minimum of 5 minutes, including induction and maintenance of anesthesia.
From the preoperative first monitorization of the patient in the operating room until extubation and transfer to the PACU (0-480 minutes).
pIOH
Time Frame: From the preoperative first monitorization of the patient in the operating room to the 20th minute after anesthesia induction.
Decrease in mean blood pressure of 30% from baseline during the first 20 min after anesthesia induction.
From the preoperative first monitorization of the patient in the operating room to the 20th minute after anesthesia induction.
mIOH
Time Frame: From the 20th minute after anesthesia induction until extubation and transfer to the PACU (between 20- 480 minutes).
Decrease of blood pressure 20th min after induction, with or without pIOH.
From the 20th minute after anesthesia induction until extubation and transfer to the PACU (between 20- 480 minutes).
PACU complications: desaturation
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Postoperative SpO2<%90
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
PACU complications: Arrhythmia
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Irregular heartbeat
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
PACU complications: Bradycardia
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Postoperative heart rate < 40 min
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
PACU complications: Tachycardia
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Postoperative heart rate >100 min >100 min-1 Heart rate >100 min-1
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
PACU complications: Gastrointestinal complications
Time Frame: Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Include nausea and vomiting
Postoperatively from the patient's arrival to the PACU until discharge (0-240 minutes).
Unplanned ICU admission
Time Frame: From the preoperative first monitorization of the patient in the operating room until until discharege from the PACU (0-720 minutes).
When ICU bed reservation is not considered in the preoperative period.
From the preoperative first monitorization of the patient in the operating room until until discharege from the PACU (0-720 minutes).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Lerzan Dogan, MD, Acibadem University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2022

Primary Completion (Actual)

November 30, 2022

Study Completion (Actual)

December 15, 2022

Study Registration Dates

First Submitted

December 21, 2022

First Submitted That Met QC Criteria

December 21, 2022

First Posted (Actual)

January 5, 2023

Study Record Updates

Last Update Posted (Actual)

January 20, 2023

Last Update Submitted That Met QC Criteria

January 18, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data on patients is available.

IPD Sharing Time Frame

1 year

IPD Sharing Access Criteria

valid reason

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypotension

Clinical Trials on Hemodynamic observation of the patients.

3
Subscribe